28
Acute Heart Failure Mefri Yanni Bagian Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1

1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Embed Size (px)

Citation preview

Page 1: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Acute Heart Failure

Mefri Yanni

Bagian Kardiologi dan Vaskuler

Fakultas Kedokteran UNAND/RSUP M DJAMIL

1

Page 2: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Classification AHF

ESC Guideline. For diagnosis and treatment of Acute and

chronic HF. 2008

Page 3: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Therapeutic Goals in AHF

3

Improve patient

hemodynamic status

to relief symptoms

and stabilize organ

function

Reduce systemic vascular

resistance (SVR)

↑cardiac output (CO)

Reduce fluid volume

and filling pressures

Reduce neurohormones

Page 4: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Assessment of

Hemodynamic Profile

Adapted from LW Stevenson

Low

Perfusion?

Congestion?

4 Possible Hemodynamic Profiles of AHF

Sign of congestion:

Orthopnea, elevated JVP, edema, pulsatile hepatomegaly ascites, rales, louder S3,P2 radiation left ward, abdomino-jugular reflex, valsava square wave

Warm/Dry

Cold/Dry

Warm/Wet

Cold/Wet

NO YES

NO

YES

A

L C

B

Sign of low perfusion:

Narrow pulse pressure, cool extremities,sleepy, suspect from ACEI hypotension, low Na, renal worsening

Page 5: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Fluid Challange Inotropic drugs :

Diuretic

Vasodilator

Warm

Dry

Cold

Wet

Warm/Dry

Cold/Dry

Warm/Wet

Cold/Wet

A

L C

B

Page 6: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Initial assessment of patient suspected AHF

ESC Guideline. For diagnosis and treatment of Acute and

chronic HF. 2012

Page 7: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

ESC Guideline. For diagnosis and treatment of Acute and

chronic HF. 2008

Page 8: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Pharmacologic option in AHF

Diuretics Vasodilators Inotropes

Reduce

fluid

volume

Decrease

preload

and

afterload

Augment

contractility

Vasodilate; reduce fluid

volume;

counteract

RAAS/SNS

Natriuretic peptides,

ACE, aldactone

RAAS = renin-angiotensin-aldosterone system; SNS = sympathetic nervous system

Page 9: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Acute Heart Failure with Systolic Dysfunction

Oxygen/CPAP

Furosemide + vasodilator

Clinical evaluation (leading to mechanistic therapy)

SBP > 100 mmHg SBP 90-100 mmHg SBP <90 mmHg

Vasodilator

(NTG, nitroprusside, BNP)

Vasodilator and/or

Inotropic (dobutamin

PDEI or Levosimendan)

Volume loading ?

Inotrope (Dopamin

> 5mcg/kg/mnt)

And/or norepinephrine

Good response

Oral therapy

Furosemide, ACE-I

No respon :

Reconside mechanistic

therapy

Inotropic agentESC, Acute Heart Failure, 2005

Page 10: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of
Page 11: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of
Page 12: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Acute management

Oxygen

Diuretics

Opiates

Vasodilators

Inotropes

Vasopressor

Page 13: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Diuretics

For achieving optimal volume status

eliminate or minimize congestion

• High doses of i.v diuretics 2-3 times

daily

• More effective with continous i.v.

• Combination diuretics

• Resistent diuretics” is a common

problem

Page 14: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Indication and dosing of diuretics in AHF

Page 15: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Morphine and its analogues

In patient present with restlessness and dyspnoea

Morphine induces • Venodilatation• Mild arterial dilatation• Reduce heart rate

Dose : 3 mg IV bolus, rate 1 mg/min.Repeated if required

ESC guidelines Acute Heart Failure, 2012

Page 16: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

VasodilatorsNitroprusside, Nitroglycerin, Nitrate family

Work by cGMP mediated smooth muscle

relaxation -> vasodilation

Decrease myocardial work by afterload

and preload reduction

May cause hypotension

May cause headache

Page 17: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Intravenous Vasodilator used to treat AHF

Page 18: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Elkayam, The American Journal of Cardiology

Nitrate

Not evaluated by large scale studies

Many studies shown their favorable effect

Limitation

Side effect

Nitrate Resistance

Nitrate Tolerance

Prevention

Intermittent dosing : 12 hour nitrate free interval

Escalating dose

Concomitant use of hydralazine

Page 19: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Felker GM. Am Heart J. 2001;142:393–401.

The use of inotropes as a treatment of :

• cardiogenic shock

• diuretic/ACE inhibitor– refractory heart failure

decompensations

• a short-term bridge to definitive treatment, such

as revascularization or cardiac transplantation,

is potentially appropriate

Role of Inotropic Therapy in Acute Heart Failure

Page 20: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Inotropic Agent

Indication :

Peripheral hypoperfusion (hypotension, decrease renal function) with or without congestion

Patients with CHF :

Clinical course, symptom and prognosis may depend on

haemodynamics parameter

Improvement of haemodynamics may become a goal of

treatment

Beneficial effect of improvement haemodynamics

potentially counteract by the rise of arrythmia (increase

oxygen demand, Ca++ loading, excessive increase in

energy) may potentially harmful ESC, Acute Heart Failure, 2012

Page 21: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Inotropes:

Dopamine, Dobutamine, Milrinone

• Improve cardiac output

- by directly increasing cardiac contractility

• Significant proarrhythmic effects

• May precipitate ischemia

• Not recommended for routine use in AHF, but

clearly have a role in specific patients

Page 22: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Inotropic Agents

Dopamine Is dose dependent and they involve in three different receptors.

In low dose (< 2 g/kgBW/min),

vasodilatation occurs predominantly in renal, coronary, and cerebral

vascular beds.

At doses > 5 g/kgBW/min dopamine

will increase peripheral vascular resistance via adrenergic receptors

However if no response is seen in diuresis the therapy should

be terminated

(Level of evidence C, class IIb)

ESC, Acute Heart Failure, 2005

Page 23: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Dobutamine

Clinical action is dose dependent positive inotropic and chronotropic effects.

In low dose induce arterial vasodilatation and in higher induce arterial vasoconstriction

Inotropic Agents

ESC, Acute Heart Failure, 2005

Page 24: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Phosphodiesterase inhibitors

Block the breakdown of cyclic AMP into

AMP (milrinone, enoximone)

In advance HF, associated with inotropic,

lusitropic, vasodilating effects

Intermediate between vasodilator and

predominant inotrope

Inotropic Agents

ESC, Acute Heart Failure, 2012

Page 25: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Drugs used to treat AHF that are positive

inotropes or vasopressor or both

Page 26: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

After stabilization

ACE-I

Beta blocker

Minelarocorticoid receptor inhibitor

Digoxin

Device therapy

Page 27: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of

Conclusion

Rapid assessment and treatment of ADHF could decreased mortality and morbidity rate

Management strategies including Ensure oxygenation

Reduce pain

Reduce fluid volume

Reduce preload and or afterload

Increase cardiac output

Identify and treat the cause of CHF

Page 28: 1 Acute Heart Failure - Cardiology Update FK UNAND Kardiologi dan Vaskuler Fakultas Kedokteran UNAND/RSUP M DJAMIL 1 Classification AHF ESC Guideline. For diagnosis and treatment of